Recurrent herpes genitalis. Treatment with Mycobacterium bovis (BCG).
D000914:Antibodies, Viral / Q000302:isolation & purification; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006561:Herpes Simplex / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007167:Immunotherapy; D007271:Injections, Intradermal; D008598:Menstruation; D009092:Mucous Membrane; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology / Q000382:microbiology; D012008:Recurrence; D012703:Serotyping; D018139:Simplexvirus / Q000302:isolation & purification; D014848:Vulvovaginitis / Q000209:etiology / Q000276:immunology / Q000628:therapy*
D000914:Antibodies, Viral; D001500:BCG Vaccine